List view / Grid view
19 February 2014 | By The European Medicines Agency
The European Medicines Agency and the United States Food and Drug AdministrationExternal link icon have set up a new 'cluster' on pharmacovigilance topics...
19 February 2014 | By Paul Wituschek, Vice President of Sales, Development and Clinical Services, Catalent
Paul Wituschek, Vice President of Sales, Development and Clinical Services, Catalent answers the question: "Other than oncology, for which disease areas do you see Antibody Drug Conjugates (ADC) being used extensively in the future?"
19 February 2014 | By Allen L. Burgenson, Manager - Regulatory Affairs, Lonza Walkersville, Inc
Allen L. Burgenson, Manager - Regulatory Affairs, Lonza Walkersville, Inc answers the question “From a vendor perspective, do you conclude that Big Pharma is still actively engaging in outsourcing of the activities that you have expertise in?”
19 February 2014 | By Edward Dell, International Marketing Director, BMG Labtech
Edward Dell, International Marketing Director, BMG Labtech answers the question "Although photomultiplier based plate-readers offer increased sensitivity compared to CCD imaging based plate-readers, they take longer to collect data from a microtitre plate. How do your customers balance throughput versus sensitivity when considering which plate-reader to purchase?"
18 February 2014 | By Avillion LLP
Avillion LLP announced it has appointed Dr Allison Jeynes-Ellis MB, ChB, FFPM as Chief Executive Officer...
17 February 2014 | By Novartis
Novartis announced that it is broadening its cancer immunotherapy research program with the acquisition of CoStim Pharmaceuticals Inc...
17 February 2014 | By The European Medicines Agency
The European Medicines Agency is pleased to welcome Dina Tsiambaou as the new Head of IT Development Department in the Information Technology Division...
17 February 2014 | By Merck
MSD Animal Health announced that following a positive opinion from the Committee for Medicinal Products for Veterinary Use, the European Commission has granted marketing authorization for the veterinary medicinal product BRAVECTO™...
17 February 2014 | By Boehringer Ingelheim
Boehringer Ingelheim Fremont Inc. received the East Bay Innovation Award in recognition for its contribution to the East Bay's culture of innovation...
17 February 2014 | By Biogen Idec
Stelios Papadopoulos to become Chairman of the Board...
14 February 2014 | By Daiichi Sankyo Company
Norovirus is one of the leading causes of infectious gastroenteritis and the number of infected people reported is increasing both in Japan and globally...
14 February 2014 | By GlaxoSmithKline
GlaxoSmithKline announced the start of a Phase III study to evaluate the efficacy and safety of mepolizumab, an investigational IL-5 antagonist, in patients with Eosinophilic Granulomatosis with Polyangiitis...
13 February 2014 | By Teva
24-month FDA post marketing commitment completed...
13 February 2014 | By Johnson & Johnson
Janssen Biotech, Inc. announced the U.S. Food and Drug Administration has approved IMBRUVICA™ (ibrutinib) capsules for the treatment of patients with chronic lymphocytic leukemia who have received at least one prior therapy...
12 February 2014 | By The European Medicines Agency
The European Medicines Agency has introduced unique product identifiers (UPIs) to track medicines through pre-authorisation procedures...
